Skip to main content
. 2017 May 9;8(31):51164–51176. doi: 10.18632/oncotarget.17737

Figure 7. Proposed scheme of ATF4 action in chemo-resistance.

Figure 7

Our data demonstrate that ATF4 counteracts chemotherapeutic agent temozolomide (TMZ). At this point, there is evidence that ATF4 drives chemo-resistance through upregulation of xCT with subsequent elevation of glutathione. Alternatively, ATF4 regulates other genes involved in blocking TMZ effects.

HHS Vulnerability Disclosure